Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Jul 12;6(13):3899-3910.
doi: 10.1182/bloodadvances.2022006987.

Storage of red blood cells in alkaline PAGGGM improves metabolism but has no effect on recovery after transfusion

Affiliations
Randomized Controlled Trial

Storage of red blood cells in alkaline PAGGGM improves metabolism but has no effect on recovery after transfusion

Sanne de Bruin et al. Blood Adv. .

Abstract

Additive solutions are used to limit changes that red blood cells (RBCs) undergo during storage. Several studies have shown better preservation of glucose and redox metabolism using the alkaline additive solution PAGGGM (phosphate-adenine-glucose-guanosine-gluconate-mannitol). In this randomized open-label intervention trial in 20 healthy volunteers, the effect of storage, PAGGGM vs SAGM (saline-adenine-glucose-mannitol), on posttransfusion recovery (PTR) and metabolic restoration after transfusion was assessed. Subjects received an autologous biotinylated RBC concentrate stored for 35 days in SAGM or PAGGGM. As a reference for the PTR, a 2-day stored autologous biotinylated RBC concentrate stored in SAGM was simultaneously transfused. RBC phenotype and PTR were assessed after transfusion. Biotinylated RBCs were isolated from the circulation for metabolomics analysis up to 24 hours after transfusion. The PTR was significantly higher in the 2-day stored RBCs than in 35-day stored RBCs 2 and 7 days after transfusion: 96% (90 to 99) vs 72% (66 to 89) and 96% (90 to 99) vs 72% (66 to 89), respectively. PTR of SAGM- and PAGGGM-stored RBCs did not differ significantly. Glucose and redox metabolism were better preserved in PAGGGM-stored RBCs. The differences measured in the blood bag remained present only until 1 day after transfusion. No differences in RBC phenotype were found besides an increased complement C3 deposition on 35-day RBCs stored in PAGGGM. Our data indicate that despite better metabolic preservation, PAGGGM is not a suitable alternative for SAGM because storage in PAGGGM did not result in an increased PTR. Finally, RBCs recovered from circulation after transfusion showed reversal of the metabolic storage lesion in vivo within a day. This study is registered in the Dutch trial register (NTR6492).

PubMed Disclaimer

Figures

None
Graphical abstract
Figure 1.
Figure 1.
Post transfusion recovery (PTR) PAGGGM stored RBCs. (A) PTR is significantly different between 35-day stored SAGM and PAGGGM RBCs over time, but not at a specific time point. (B) Thirty-five days of storage in SAGM results in decreased PTR compared with 2 days of storage in SAGM. The line plot indicates the median with 25th and 75th percentile of PTR over time, up to 90 days after transfusion.
Figure 2.
Figure 2.
Metabolomics data of glycolysis metabolites comparing 35-day stored RBCs in SAGM with 35-day stored RBCs in PAGGGM. The boxplots show metabolite levels in RBCs before transfusion. Line plots indicate the median with 25th and 75th percentile of metabolite concentrations over time in the recovered RBCs, up to 1 day after transfusion.*P < .05, **P < .01, and ***P < .0001; NS, not statistically significant.
Figure 3.
Figure 3.
Metabolomics data of PPP and glutathione-related metabolites comparing 35-day stored RBCs in SAGM and 35-day stored RBCs in PAGGGM. The boxplots show metabolite concentrations in RBCs before transfusion. Line plots indicate the median with 25th and 75th percentile of metabolite concentrations over time in the recovered RBCs, up to 1 day after transfusion. *P < .05, **P < .01, and ***P < .0001; NS, not statistically significant.
Figure 4.
Figure 4.
Metabolome of RBCs in stored in SAGM and PAGGGM. Purine (A) and free fatty acid metabolism (B) comparing 35-day stored RBCs in SAGM and 35-day stored RBCs in PAGGGM. The boxplots show metabolite concentrations in RBCs before transfusion. Line plots indicate the median with 25th and 75th percentile of metabolite concentrations over time in the recovered RBCs, up to 1 day after transfusion. *P < .05, **P < .01, and ***P < .0001; NS, not statistically significant.
Figure 5.
Figure 5.
Metabolomics data of glycolysis-related metabolites comparing RBCs stored for 2 and 35 days in SAGM. The boxplots show metabolite concentrations in RBCs before transfusion. Line plots indicate the median with 25th and 75th percentile of metabolite concentrations over time in the recovered RBCs, up to 1 day after transfusion. *P < .05, **P < .01, and ***P < .0001; NS, not statistically significant.
Figure 6.
Figure 6.
G6PD activity in 35-day stored RBCs. Comparing storage in SAGM with PAGGGM (A) and comparing 2- and 35-day stored RBCs (B). The bar chart represents the mean + standard deviation of G6PD activity of RBCs in the transfusion bag before transfusion. The line chart depicts the mean ± standard deviation of G6PD activity in the recovered RBCs after transfusion.
Figure 7.
Figure 7.
Metabolomics data of PPP and glutathione-related metabolites comparing RBCs stored for 2 days or 35 days in SAGM. The boxplots show metabolite concentrations in RBCs before transfusion. Line plots indicate the median with 25th and 75th percentile of metabolite concentrations over time in the recovered RBCs, up to 1 day after transfusion. *P < .05, **P < .01, and ***P < .0001; NS, not statistically significant.

Similar articles

Cited by

References

    1. Luten M, Roerdinkholder-Stoelwinder B, Schaap NPM, de Grip WJ, Bos HJ, Bosman GJ. Survival of red blood cells after transfusion: a comparison between red cells concentrates of different storage periods. Transfusion. 2008;48(7):1478-1485. - PubMed
    1. Zeiler T, Müller JT, Kretschmer V. Flow-cytometric determination of survival time and 24-hour recovery of transfused red blood cells. Transfus Med Hemother. 2003;30(1):14-19.
    1. Dumont LJ, AuBuchon JP. Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trials. Transfusion. 2008;48(6):1053-1060. - PubMed
    1. Bolton-Maggs PHB. SHOT conference report 2016: serious hazards of transfusion - human factors continue to cause most transfusion-related incidents. Transfus Med. 2016;26(6):401-405. - PubMed
    1. Goldman M, Webert KE, Arnold DM, Freedman J, Hannon J, Blajchman MA; TRALI Consensus Panel . Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev. 2005;19(1):2-31. - PubMed

Publication types